• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
94.99 0.39
(0.42%)
EUR-INR
108.21 0.30
(0.28%)
GBP-INR
125.93 0.66
(0.53%)
JPY-INR
0.58 0.00
(0.27%)

EQUITY - MARKET SCREENER

Parmax Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
540359
INE240T01014
-18.3323978
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
31.01
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

bn holdings ltd
NELCO reports consolidated net profit of Rs 1.09 crore in the March 2026 quarter
Apr 21,2026
Net profit of NELCO reported to Rs 1.09 crore in the quarter ended March 2026 as against net loss of Rs 4.08 crore during the previous quarter ended March 2025. Sales rose 17.27% to Rs 79.18 crore in the quarter ended March 2026 as against Rs 67.52 crore during the previous quarter ended March 2025.

For the full year,net profit declined 65.16% to Rs 3.32 crore in the year ended March 2026 as against Rs 9.53 crore during the previous year ended March 2025. Sales rose 0.57% to Rs 306.60 crore in the year ended March 2026 as against Rs 304.87 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales79.1867.52 17 306.60304.87 1
OPM %6.919.54 -9.3213.77 -
PBDT6.677.56 -12 28.3541.82 -32
PBT1.751.13 55 8.4019.66 -57
NP1.09-4.08 LP 3.329.53 -65